Anlotinib as Monotherapy or Combination Therapy for Recurrent High-Grade Glioma: A Retrospective Study

BACKGROUND: Anlotinib is a multi-target anti-angiogenic agent. The retrospective study was conducted to evaluate the safety and effectiveness of anlotinib as monotherapy or combination therapy for the treatment of recurrent high-grade gliomas. METHODS: In this retrospective study, patients with recu...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Jun, Yin, Wenya, Zheng, Linlin, Li, Yimin, Luo, Cheng, Zhang, Shuo, Duan, Lei, Zhou, Hang, Cheng, Kai, Lang, Jinyi, Xu, Ke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331188/
https://www.ncbi.nlm.nih.gov/pubmed/37435019
http://dx.doi.org/10.1177/11795549231175714

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331188/
https://www.ncbi.nlm.nih.gov/pubmed/37435019
http://dx.doi.org/10.1177/11795549231175714

Ejemplares similares